Semaglutide Therapy for Alcohol Reduction (STAR)
Phase 2
52
about 7.2 years
18–110
1 site in MD
What this study is about
This trial is testing if Semaglutide, a medication, can help people with alcohol use disorder reduce their drinking. Participants will receive either Semaglutide or a placebo shot weekly and undergo various tests to monitor their progress.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Control
- 2.Take Semaglutide
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
semaglutide (GLP-1 agonist; stimulates insulin release)
oral (Oral Tablet)
Primary: Determine the safety and tolerability of semaglutide in individuals with AUD.
Secondary: Determine whether semaglutide reduces blood Phosphatidylethanol (PEth) levels as a biomarker of alcohol use.
Psychiatry / Mental Health